{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:09:18Z","timestamp":1795140558249,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triggering receptor expressed on myeloid cells-1 (TREM-1) is one of the more recently described biomarkers for sepsis and currently of great interest, as an inhibitor called nangibotide (Inotrem, Paris, France) for TREM-1 has made it into a phase 3 study for the treatment of sepsis. TREM-1, as a pattern recognition receptor (PRRs), plays a crucial role in the immune defense of the host. Several studies revealed promising results for soluble TREM-1 (sTREM-1) as a biomarker for outcome prediction. However, its usefulness in different subgroups of sepsis and the cut-off threshold at which patients are exposed to a higher risk of mortality have not yet been sufficiently investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study is a secondary analysis of data and sTREM-1 measurements from plasma samples obtained in the prospective, observational, non-interventional, multicentric Next GeneSiS-Trial (DRKS00011911). We aimed to characterize the role of sTREM-1 in septic and septic shock patients in a large cohort with regard to different pre-existing factors, infectious aspects and outcome parameters. Furthermore, we investigated the influence of sTREM-1 cut-offs previously described from Francois et al. on different outcome parameters. Therefore, data from 500 patients were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median sTREM-1 values were statistically significant higher in patients with septic shock than in septic patients (406 (IQR;270\u2013650) pg\/mL vs. 293 (IQR;189\u2013489) pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Non-survivors, patients with the need of renal replacement therapy, mechanical ventilation or a positive Sepsis-Induced-Coagulopathy (SIC) score presented with statistically significant higher sTREM-1 values (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). sTREM-1 levels were significantly higher in patients in the highest quartile for fluid balance and Sequential Organ Failure Assessment score, and significantly lower in those in the highest quartile for Horowitz Index and platelet count (PSSC). sTREM-1 levels showed slight but statistically significant differences based on the site of infection or blood culture results on day one; however, these differences were no longer detectable by day three. The best cut-off of sTREM-1 values to differentiate between survival and non-survival on day 28 was 408 (CI;297\u2013505) pg\/ml in our study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated sTREM-1 concentrations particularly occur in patients with a high degree of organ damage, who are at high risk for adverse outcomes. In addition, the primary site of infection may be of relevance for the sTREM-1 increase. These characteristics support its suitability as a biomarker across different causes of sepsis and highlights its potential as a therapeutic target. A cut-off value exceeding 400 pg\/mL has shown robust diagnostic performance across multiple studies. Our results support this observation, indicating that this threshold may be useful for future clinical and research applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06025-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:58:24Z","timestamp":1776790704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Soluble triggering receptor expressed on myeloid cells-1 as a predictive biomarker in sepsis: insights into cut-offs, mortality risk, and treatment guidance\u2014secondary analysis of the Next GeneSiS-Trial"],"prefix":"10.1186","volume":"30","author":[{"given":"Vivienne","family":"Theobald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Gregorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian O.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fei\u00dft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Herbstreit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nusshag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabell","family":"Skarabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C. F.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the German Society of Anaesthesiology and Intensive Care (GSAIC) Trials Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevhen","family":"Vainshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Grumaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Manoochehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Seidel-Glatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Fuest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Blobner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onnen","family":"Moerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Brandenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dimski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudiusz","family":"Suchodolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"J\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zischkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sch\u00fcrholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lindau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Putensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirak","family":"Petros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Gaasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00f6rg","family":"Gillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"10219","key":"6025_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"1","key":"6025_CR2","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1503\/cmaj.160798","volume":"189","author":"S Dugani","year":"2017","unstructured":"Dugani S, Veillard J, Kissoon N. Reducing the global burden of sepsis. CMAJ: Can Med Association J = J de l\u2019Association medicale canadienne. 2017;189(1):E2\u20133.","journal-title":"CMAJ: Can Med Association J = J de l\u2019Association medicale canadienne"},{"issue":"1","key":"6025_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3947\/ic.2020.52.1.1","volume":"52","author":"MH Kim","year":"2020","unstructured":"Kim MH, Choi JH. An update on sepsis biomarkers. Infect Chemother. 2020;52(1):1\u201318.","journal-title":"Infect Chemother"},{"issue":"Suppl 4","key":"6025_CR4","first-page":"7","volume":"10","author":"BM Biron","year":"2015","unstructured":"Biron BM, Ayala A, Lomas-Neira JL. Biomarkers for sepsis: what is and what might be? Biomark Insights. 2015;10(Suppl 4):7\u201317.","journal-title":"Biomark Insights"},{"key":"6025_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00267","volume":"9","author":"D Hildebrand","year":"2019","unstructured":"Hildebrand D, Decker SO, Koch C, Schmitt FCF, Ruhrmann S, Schneck E, et al. Host-derived delta-like canonical notch ligand 1 as a novel diagnostic biomarker for bacterial sepsis-results from a combinational secondary analysis. Front Cell Infect Microbiol. 2019;9:267.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"6025_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jama.2016.20328","volume":"317","author":"EP Raith","year":"2017","unstructured":"Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290\u2013300.","journal-title":"JAMA"},{"issue":"1","key":"6025_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/cc3913","volume":"10","author":"KM Ho","year":"2005","unstructured":"Ho KM, Dobb GJ, Knuiman M, Finn J, Lee KY, Webb SAR. A comparison of admission and worst 24-hour acute physiology and chronic health evaluation II scores in predicting hospital mortality: a retrospective cohort study. Crit Care. 2005;10(1):R4.","journal-title":"Crit Care"},{"issue":"24","key":"6025_CR8","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270(24):2957\u201363.","journal-title":"JAMA"},{"issue":"10","key":"6025_CR9","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-2600(23)00158-3","volume":"11","author":"B Fran\u00e7ois","year":"2023","unstructured":"Fran\u00e7ois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet Respir Med. 2023;11(10):894\u2013904.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6025_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04798-2","volume":"28","author":"V Theobald","year":"2024","unstructured":"Theobald V, Schmitt FCF, Middel CS, Gaissmaier L, Brenner T, Weigand MA. Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies. Crit Care. 2024;28(1):17.","journal-title":"Crit Care"},{"issue":"10","key":"6025_CR11","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (Baltimore Md: 1950). 2000;164(10):4991\u20135.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"6832","key":"6025_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/35074114","volume":"410","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103\u20137.","journal-title":"Nature"},{"key":"6025_CR13","doi-asserted-by":"crossref","unstructured":"Roe K, Gibot S, Verma S. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? 2014;5.","DOI":"10.3389\/fmicb.2014.00627"},{"key":"6025_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.02.043","volume":"177","author":"A Tammaro","year":"2017","unstructured":"Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81\u201395.","journal-title":"Pharmacol Ther"},{"key":"6025_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-981-13-3065-0_18","volume":"1112","author":"A Gulati","year":"2018","unstructured":"Gulati A, Kaur D, Krishna Prasad GVR, Mukhopadhaya A. PRR function of innate immune receptors in recognition of bacteria or bacterial ligands. Adv Exp Med Biol. 2018;1112:255\u201380.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"6025_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23(9):580\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6025_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0312145","volume":"93","author":"RJ Arts","year":"2013","unstructured":"Arts RJ, Joosten LA, van der Meer JW, Netea MG. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 2013;93(2):209\u201315.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"6025_CR18","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.4049\/jimmunol.1102674","volume":"188","author":"M Derive","year":"2012","unstructured":"Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol. 2012;188(11):5585\u201392.","journal-title":"J Immunol"},{"key":"6025_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106565","author":"T Brenner","year":"2025","unstructured":"Brenner T, Decker SO, Vainshtein Y, Grumaz S, Manoochehri M, Fei\u00dft M, et al. Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencing. J Infect. 2025. https:\/\/doi.org\/10.1016\/j.jinf.2025.106565.","journal-title":"J Infect"},{"issue":"12","key":"6025_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect diseases: official publication Infect Dis Soc Am. 2008;46(12):1813\u201321.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"9","key":"6025_CR21","doi-asserted-by":"publisher","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.","journal-title":"BMJ Open"},{"key":"6025_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1525538","volume":"12","author":"T Schmoch","year":"2025","unstructured":"Schmoch T, M\u00f6hnle P, Nusshag C, Feisst M, Weigand MA, Brenner T. Impending sepsis-induced coagulopathy (SIC) is associated with increased disease severity in SIC-negative patients: a secondary analysis of a prospective exploratory study. Front Med. 2025;12:1525538.","journal-title":"Front Med"},{"issue":"4","key":"6025_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106458","volume":"90","author":"V Theobald","year":"2025","unstructured":"Theobald V, Bloos F, Bauer M, Brenner T, von der Forst M, Meybohm P, et al. Host-derived delta-like canonical notch ligand-1 in sepsis and septic shock: infection site, pathogens and disease severity matter \u2013 secondary analysis of data from a randomized controlled trial. J Infect. 2025;90(4):106458.","journal-title":"J Infect"},{"key":"6025_CR24","unstructured":"de Costa SX, Da Costa Sigrist N, Dolhnikoff G, Ferraz Da Silva M. LF. RAGE expression in lung tissue of ARDS and septic patients. Eur Respir J.56(suppl 64):2752."},{"issue":"1","key":"6025_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/cc6187","volume":"12","author":"MA van Zoelen","year":"2008","unstructured":"van Zoelen MA, van der Poll T. Targeting RAGE in sepsis. Crit Care. 2008;12(1):103.","journal-title":"Crit Care"},{"issue":"5","key":"6025_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/cc3732","volume":"9","author":"S Gibot","year":"2005","unstructured":"Gibot S. Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care. 2005;9(5):485\u20139.","journal-title":"Crit Care"},{"issue":"14","key":"6025_CR27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/CM9.0000000000003197","volume":"137","author":"Y Fan","year":"2024","unstructured":"Fan Y, Xu Y, Huo Z, Zhang H, Peng L, Jiang X, et al. Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: a biomarker and potential therapeutic target. Chin Med J. 2024;137(14):1663\u201373.","journal-title":"Chin Med J"},{"issue":"1","key":"6025_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01380-5","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Levy JH. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensive Care. 2024;14(1):148.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"6025_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124222","volume":"14","author":"T Schmoch","year":"2025","unstructured":"Schmoch T, M\u00f6hnle P, Weigand MA, Dietrich M, Gregorius J, Frank S, et al. Incidence of Sepsis-Induced Coagulopathy (INSIC) trial: study protocol of a combined retrospective and prospective, multicenter, international, cross-sectional, longitudinal, and epidemiological observational trial. J Clin Med. 2025;14(12):4222.","journal-title":"J Clin Med"},{"issue":"1","key":"6025_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-01093-7","volume":"13","author":"T Schmoch","year":"2023","unstructured":"Schmoch T, M\u00f6hnle P, Weigand MA, Briegel J, Bauer M, Bloos F, et al. The prevalence of sepsis-induced coagulopathy in patients with sepsis \u2013 a secondary analysis of two German multicenter randomized controlled trials. Ann Intensive Care. 2023;13(1):3.","journal-title":"Ann Intensive Care"},{"issue":"5","key":"6025_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/cc10508","volume":"15","author":"LX Su","year":"2011","unstructured":"Su LX, Feng L, Zhang J, Xiao YJ, Jia YH, Yan P, et al. Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study. Crit Care. 2011;15(5):R250.","journal-title":"Crit Care"},{"issue":"5","key":"6025_CR32","first-page":"342","volume":"56","author":"ZK Yuan","year":"2018","unstructured":"Yuan ZK, Fang F, Liu CJ, Li J, Chen YF, Xu F. [Value of urine soluble triggering receptor expressed on myeloid cells-1 in the early diagnosis of sepsis associated acute kidney injury]. Zhonghua er ke za zhi\u2009=\u2009Chinese journal of pediatrics. 2018;56(5):342\u20136.","journal-title":"Zhonghua er ke za zhi\u2009=\u2009Chinese journal of pediatrics"},{"issue":"6","key":"6025_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/cc10533","volume":"15","author":"M Derive","year":"2011","unstructured":"Derive M, Gibot S. Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury. Critical care (London, England). 2011;15(6):1013.","journal-title":"Critical care (London, England)"},{"issue":"5","key":"6025_CR34","first-page":"1155","volume":"41","author":"Y Molad","year":"2023","unstructured":"Molad Y, Egbaria M, Tovar A, Dortort Lazar A, Pokroy Shapira E, Oren S, et al. Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study. Clin Exp Rheumatol. 2023;41(5):1155\u201362.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"6025_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2213-2600(23)00220-5","volume":"11","author":"M Neupane","year":"2023","unstructured":"Neupane M, Kadri SS. Nangibotide for precision immunomodulation in septic shock and COVID-19. Lancet Respir Med. 2023;11(10):855\u20137.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6025_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27215-6","volume":"12","author":"A Leligdowicz","year":"2021","unstructured":"Leligdowicz A, Conroy AL, Hawkes M, Richard-Greenblatt M, Zhong K, Opoka RO, et al. Risk-stratification of febrile African children at risk of sepsis using sTREM-1 as basis for a rapid triage test. Nat Commun. 2021;12(1):6832.","journal-title":"Nat Commun"},{"key":"6025_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmaf074","author":"P Bautista-Carbajal","year":"2025","unstructured":"Bautista-Carbajal P, Ch\u00e1vez-P\u00e9rez JP, Garc\u00eda-Le\u00f3n ML, Cabrera-S\u00e1nchez JA, Baltazar-L\u00f3pez N, Zaldivar-Ramirez FR, et al. sTREM-1 as a biomarker for sepsis diagnosis and prognosis following abdominal surgery. Lab Med. 2025. https:\/\/doi.org\/10.1093\/labmed\/lmaf074.","journal-title":"Lab Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06025-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:30:33Z","timestamp":1781649033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06025-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6025"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06025-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a secondary analysis through evaluating the data from the prospective, observational, non-interventional, multicentric Next GeneSiS-Trial (DRKS00011911) [\n                      \n                      ]. The local responsible ethic committee has approved the conduction of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SOD received scientific grants from Heidelberg Foundation of Surgery and B.Braun Foundation, Melsungen, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}